Rank 61 • AI & Clinical Intelligence
Harrison.ai
Partners with clinical leaders to co-develop and scale AI diagnostic tools for radiology, pathology, and clinical workflows.
Visit website- Signal Score
- 84.8
- Total raised
- $95M
- Stage
- Series B
- Founded
- 2018
- Headquarters
- Sydney, Australia
- Region
- Asia-Pacific
Their signal
Through powerful joint ventures like Franklin.ai and Annalise.ai, Harrison.ai scales regulatory-approved AI imaging tools globally, supported by top-tier APAC healthcare groups.
Signal Score 84.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.